Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms NR-7h |
Target |
Action inhibitors |
Mechanism MAPK11 inhibitors(mitogen-activated protein kinase 11 inhibitors), p38α inhibitors(P38 α mitogen-activated protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC48H50BrF2N9O8 |
InChIKeyBEMLUUUHZPFCBS-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Spain | 18 Jun 2020 |